Ray Dalio’s Enovis ENOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.17M | Buy |
+51,224
| New | +$1.21M | 0.01% | 767 |
|
|
2025
Q1 | – | Sell |
-5,915
| Closed | -$260K | – | 715 |
|
|
2024
Q4 | $260K | Sell |
5,915
-11,673
| -66% | -$513K | ﹤0.01% | 647 |
|
|
2024
Q3 | $757K | Buy |
17,588
+7,823
| +80% | +$349K | ﹤0.01% | 635 |
|
|
2024
Q2 | $441K | Sell |
9,765
-192
| -2% | -$9.96K | ﹤0.01% | 763 |
|
|
2024
Q1 | $622K | Sell |
9,957
-1,935
| -16% | -$116K | ﹤0.01% | 607 |
|
|
2023
Q4 | $666K | Sell |
11,892
-3,172
| -21% | -$158K | ﹤0.01% | 678 |
|
|
2023
Q3 | $794K | Sell |
15,064
-40,932
| -73% | -$2.39M | ﹤0.01% | 641 |
|
|
2023
Q2 | $3.59M | Sell |
55,996
-3,083
| -5% | -$176K | 0.02% | 368 |
|
|
2023
Q1 | $3.16M | Buy |
59,079
+42,637
| +259% | +$2.47M | 0.02% | 385 |
|
|
2022
Q4 | $880K | Sell |
16,442
-47,041
| -74% | -$2.43M | ﹤0.01% | 657 |
|
|
2022
Q3 | $2.92M | Sell |
63,483
-4,853
| -7% | -$263K | 0.01% | 482 |
|
|
2022
Q2 | $3.76M | Buy |
+68,336
| New | +$4.41M | 0.02% | 560 |
|
|
2021
Q1 | – | Sell |
-6,696
| Closed | -$441K | – | 500 |
|
|
2020
Q4 | $441K | Buy |
6,696
+1,322
| +25% | +$77.3K | ﹤0.01% | 476 |
|
|
2020
Q3 | $290K | Buy |
+5,374
| New | +$295K | ﹤0.01% | 421 |
|
|
2019
Q1 | – | Sell |
-14,416
| Closed | -$519K | – | 370 |
|
|
2018
Q4 | $519K | Buy |
+14,416
| New | +$673K | ﹤0.01% | 389 |
|
|
2018
Q3 | – | Sell |
-6,640
| Closed | -$350K | – | 400 |
|
|
2018
Q2 | $350K | Sell |
6,640
-7,876
| -54% | -$426K | ﹤0.01% | 404 |
|
|
2018
Q1 | $797K | Buy |
+14,516
| New | +$895K | 0.01% | 313 |
|
|
2017
Q3 | – | Sell |
-3,630
| Closed | -$246K | – | 318 |
|
|
2017
Q2 | $246K | Buy |
+3,630
| New | +$248K | ﹤0.01% | 309 |
|
|
2015
Q4 | – | Sell |
-67,570
| Closed | -$3.48M | – | 318 |
|
|
2015
Q3 | $3.48M | Buy |
67,570
+52,061
| +336% | +$3.45M | 0.05% | 168 |
|
|
2015
Q2 | $1.23M | Buy |
+15,509
| New | +$1.31M | 0.01% | 220 |
|
|
2014
Q4 | – | Sell |
-4,682
| Closed | -$459K | – | 366 |
|
|
2014
Q3 | $459K | Buy |
+4,682
| New | +$526K | ﹤0.01% | 288 |
|
|
2014
Q1 | – | Sell |
-9,213
| Closed | -$1.01M | – | 360 |
|
|
2013
Q4 | $1.01M | Buy |
9,213
+1,743
| +23% | +$175K | 0.01% | 211 |
|
|
2013
Q3 | $726K | Buy |
+7,470
| New | +$689K | 0.01% | 236 |
|
Other funds holding ENOV
VPM
VCM
RCMNY
DC
PCMI
HRCM
Ray Dalio's ENOV Position: Q1 2026 in Review
Ray Dalio opened a new position in Enovis (ENOV) in Q1 2026: 51,224 shares worth $1.17M. The stake represents 0.01% of the portfolio and ranks #767 among its holdings. This is a return to the name: Ray Dalio previously reported a position in ENOV as recently as Q4 2024.
Ray Dalio first reported a position in ENOV in Q3 2013 and has held it in 23 quarters since. The position peaked at $3.76M in Q2 2022. 254 funds tracked by Wall St. Rank hold ENOV as of Q1 2026.
- Ray Dalio held 51,224 shares of Enovis worth $1.17M as of Q1 2026.
- Enovis was a new Ray Dalio position in Q1 2026.
- Enovis made up 0.01% of Ray Dalio's portfolio in Q1 2026, its #767 holding.
- Ray Dalio first reported a position in Enovis in Q3 2013 and has held it in 23 quarters since.
- Ray Dalio's Enovis position peaked at $3.76M in Q2 2022.
- 254 funds tracked by Wall St. Rank held Enovis as of Q1 2026.
Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.